Table 1.
Baseline clinical data of 71 patients involved in the presence work
| Characters | Number (%) |
|---|---|
| Median age, year (range) | 54 (27–65) |
| Gender, male (%) | 66 (92.93%) |
| Aetiology (%) | |
| HBV positive | 58 (81.69%) |
| HCV positive | 4 (5.63%) |
| BCLC stages | |
| A | 63 (88.73%) |
| B | 8 (11.27%) |
| ECOG PS (%) | |
| 0 | 35 (49.30%) |
| 1 | 32 (45.07%) |
| 2 | 4 (5.63%) |
| AFP (%) | |
| Normal | 16 (16.90%) |
| Elevated | 55 (77.46%) |
| Extrahepatic metastasis (%) | 2 (2.82%) |
| LN metastasis (%) | 6 (8.45%) |
| Portal vein invasion (%) | – |
| Chilg-Pugh (%) | |
| A | 58 (81.69%) |
| B | 13 (18.31%) |
| C | – |
| Median size of index tumor, cm (range) | 3.5 (1.8–4.9) |
| Median number of index tumors | 2 (1–4) |
| Prior local therapy (%) | None |